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Background/aim: The aim of this study was to determine the prevalence of cardiovascular risk factors (CVRF) and the level of
cardiovascular risk (CVR), determined with different scales (REGICOR, SCORE, ERICE, vascular age...) in people with low and normal
weight.
Materials and Methods: A total of 192,711 underweight and normal weight Spanish workers participated. CVR parameters included
were weight, abdominal circumference, blood pressure, glycemia (high >125 mg/dL or under hypoglycemic treatment) and lipids (cutoff points: total cholesterol 200 mg/dL, LDL 130 mg/dL, triglycerides 150 mg/dL) were obtained by automated enzymatic methods.
Body mass index (BMI) was calculated, considering underweight 18.5 and normal weight 18.5–24.9. A descriptive analysis of the
categorical variables was carried out.
Results: The values of analytical, anthropometric and clinical parameters were more unfavorable in the normal weight group. Also,
the prevalence of alterated values of CVR seen with different scales show higher risk in this group and in all cases the values in men
are worse. It was seen that the variable with the greatest influence on the appearance of altered values of the cardiovascular risk scales
(CVRS), influencing all of them was the age.
Conclusion: All the CVRS analyzed showed higher values in the group of people with normal weight compared to those with
underweight. Age, followed by sex, were the variables that most influence the appearance of high CVR values.
Key words: Cardiovascular risk, body mass index (BMI), weight

1. Background/aim
The CVR of any population is directly related to the
prevalence of the different risk factors and to the impact
that each of them may have on morbidity and mortality
due to cardiovascular disease (CVD).
Obesity, classically understood as a body mass
index greater than 30 kg/m2, is considered a chronic
and multifactorial pathology [1,2]. The World Health
Organization (WHO) defines obesity as excessive body
fat accumulation, which is associated with several risks
to health [2]. In recent decades, it has reached epidemic
proportions, with serious social and psychological
consequences, affecting all socioeconomic groups and
all ages [3]. Many factors have led to this uncontrolled
growth in obesity, including the increase in the
consumption of high-calorie foods [4,5], the increase
in sedentary lifestyles due to a change in entertainment
patterns, mainly due to the replacement of leisure

time related to physical activity by sedentary activities
(television, electronic devices) [6,7]. Many studies have
already linked obesity to an increase in cardiovascular
mortality and mortality from other causes [8]. It is also
known that obesity is a CVRF in itself [9,10].
Just as we have seen that the relationship between
excess weight and CVD or risk has been extensively
studied, the level of CVR in people with body mass
index (BMI) below 25 kg/m2, and especially below 18.5
kg/m2, i.e. people with low and normal weight, is not as
well known. The BMI is used as an indicator of excess
body fat, but it only provides an approximation of body
fat and does not reveal fat distribution. Furthermore, the
same parameters are used for the worldwide population,
without making differences in some risk factors that can
be important when estimating CVR [11]. Sometimes,
individuals can be misclassified as not being at risk or
over classified as being at risk without having it.
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For this reason, the aim of this study was to determine
the prevalence of CVRFs and the level of CVR, determined
with different scales such as REGICOR, SCORE, ERICE
and vascular age, in people with low and normal weight.
2. Materials and methods
A cross-sectional study was carried out in a group of
192,711 underweight and normal weight workers from
different Spanish geographic areas between January
2019 and July 2020. Workers were selected from among
those who went to periodic occupational health medical
examinations considering the following inclusion criteria:
• Be actively working.
• Accepted their voluntary participation in the study
and authorized the use of data for epidemiological
purposes.
• No previous serious CVD (myocardial infarction,
cerebrovascular disease, etc.).
• BMI under 25 kg/m2.
• The Figure is a representative flowchart of participants
included in the study.
The different anthropometric, analytical and clinical
determinations were performed by health professionals
from the occupational health units participating in the
study, after homogenizing the measurement techniques.

1.1. Cardiovascular risk parameters included in the
assessment
Weight (in kg) and height (in cm) were measured with
a SECA 700 measuring rod and a SECA 220 telescopic
measuring rod with millimeter division.
Abdominal circumference (in cm) was determined
with a SECA 200 tape measure and with the person in a
standing position and the abdomen relaxed, placing the
tape measure at the height of the last floating rib.
Blood pressure was measured with a calibrated
OMRON M3 automatic sphygmomanometer after 10
min rest. The mean of three measurements was obtained.
We considered hypertension to be values of 140 mm Hg
systolic or 90 mm Hg diastolic. Blood tests were obtained
by peripheral venipuncture after fasting for 12 h.
Glycemia, total cholesterol and triglycerides were
obtained by automated enzymatic methods, HDL were
determined by precipitation with dextran sulfate MgCl2,
and LDL (mg/dl) were calculated by Friedewald formula
(provided triglycerides were <400 mg/dLl).
Friedewald formula: LDL = total cholesterol – HDL –
triglycerides / 5.
All values are expressed in mg/dL. Glycemia was
considered high if the values were greater than 125 mg/dL
or if the patient was under hypoglycemic treatment [12].

Figure. Flowchart of participants. BMI: body mass index, CVD:
cardiovascular disease, KG: kilogram, m: meter
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The following cut-off points are established for lipids: total
cholesterol 200 mg/dL, LDL 130 mg/dL and triglycerides
150 mg/dL. BMI was calculated by dividing weight by
height in squared meters. Underweight was considered
under 18.5 and normal weight between 18.5 and 24.9.
REGICOR (adaptation of the Framingham scale to the
Spanish population) [13] estimates the risk of suffering a
cerebrovascular event over a 10-year period. It is applied
between 35 and 74 years of age. The risk is moderate at 5%
and high at 10% or higher [14].
The SCORE scale applied in the Spanish population
[15,16] estimates the risk of suffering a fatal cerebrovascular
event over a 10-year period. It is applied between 40 and 65
years of age. The risk is moderate in >4% and high in >5%.
Calibrated tables were used to determine vascular age [17].
Vascular age with the Framingham model [17] can be
calculated in persons over 30 years of age, whereas vascular
age with the SCORE model [18] between 40 and 65 years.
An interesting concept applicable to both vascular ages
is ALLY (avoidable years of life lost) [19], which can be
defined as the difference between biological age (BA) and
vascular age (VA).
ALLY = VA – BA.
A person is considered to be a smoker if he/she has
regularly consumed one or more cigarettes per day (or the
equivalent in other types of consumption) during the last
month, or if he/she has quit smoking less than 12 months
ago.
Social class is determined from the 2011 National
Classification of Occupations (CNO-11) according to
the proposal of the Spanish Society of Epidemiology
[20]. Three social classes are differentiated: I. Directors/
managers, university professionals, athletes and artists.
II. Intermediate occupations and self-employed workers
without employees. III. Unskilled workers.
2.2 Statistical analysis
A descriptive analysis of the categorical variables was
carried out, calculating the frequency and distribution
of responses for each of them. For quantitative variables,
the mean and standard deviation were calculated, and
for qualitative variables the percentage was calculated.
A bivariate association analysis was performed using
the χ2 test (with a correction with the Fisher’s exact test,
when conditions required so) and a Student’s t-test for
independent samples. For the multivariate analysis, binary
logistic regression was used with the Wald method, with
an odds ratio calculation and a Hosmer–Lemeshow
goodness-of-fit test. Statistical analysis was performed
with the SPSS 27.0 program, and a p value of <0.05 was
considered as statistically significant.
2.3 Ethical considerations and aspects
The study was approved by the Clinical Research Ethics
Committee of the Health Area of Balearic Islands in
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November 2020. All procedures were performed in
accordance with the ethical standards of the institutional
research committee and with the 2013 Declaration of
Helsinki. All patients signed written informed consent
documents prior to participation in the study.
3. Results
The mean values of analytical, anthropometric and clinical
parameters, in both sexes, are more unfavorable in the
normal weight group than in the underweight group. In
all cases, the values in men are worse than in women.
The prevalence of smoking is higher in women and in
underweight individuals. All the data are presented in
Table 1.
The CVRS analyzed show higher values in the normal
weight group in both sexes, although the differences are
only statistically significant in the case of vascular age with
the Framingham model. All the values, as we have seen
above, are more unfavorable among men. The complete
data are shown in Table 2.
The prevalence of altered values of scales related to CVR
follows the same trend seen with the mean values, that is,
the worst results are found in the normal weight group.
The prevalences are also higher in men. The differences
are only statistically significant for hypertension and lipid
profile. The complete data can be found in Table 3.
Multivariate analysis by binary logistic regression with
the Wald method included age 50 years or older, smoking,
male sex, and social class III as covariates. Age was the
variable with the greatest influence on the appearance of
altered values of the CVRS, influencing all of them. Male
sex was the second most influential variable, affecting all
the scales except elevated LDL cholesterol. Belonging to
the normal weight group increased the risk compared to
the underweight group in all scales except diabetes. The
least influential variable was tobacco consumption. The
complete data set is presented in Table 4.
4. Discussion
It is known that there are various parameters that influence
the appearance of high CVR and therefore the development
of acute and chronic diseases that increase morbidity
and mortality in the general population [1,2,9,10]. The
lifestyle of the current world population, with a tendency
to sedentary and an unhealthy lifestyle, has increased the
risk of developing pathologies [21].
Most of the studies that refer to CVR are carried out in
populations with overweight and/or obesity and there are
few studies referring to our research topic, carried out in a
population with normal weight or underweight.
In our study, all the CVRS analyzed showed unfavorable
values in the group of people with normal weight compared
to those with underweight. Age, followed by sex, are the
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Table 1. Sociodemographic, anthropometric, clinical and analytical characteristics of the sample.
Underweight

Normal weight

Underweight

Normal weight

Women n = 5768

Women n = 91,309

Men n = 2448

Men n = 93,186

Mean (SD)

Mean (SD)

p-value

Mean (SD)

Mean (SD)

p-value

Age

33.05 (9.75)

37.92 (10.43)

<0.0001

30.93 (11.05)

37.14 (10.92)

<0.0001

Height

163.49 (6.37)

162.37 (6.35)

<0.0001

175.91 (7.09)

175.16 (6.94)

0.124

Weight

47.20 (4.17)

58.18 (6.20)

<0.0001

54.67 (4.94)

70.00 (7.34)

<0.0001

Waist

63.93 (5.10)

69.56 (6.04)

<0.0001

70.26 (7.46)

78.58 (7.32)

<0.0001

SBP

108.62 (13.00)

113.80 (13.94)

<0.0001

117.96 (13.78)

123.40 (13.80)

<0.0001

DBP

67.67 (9.00)

70.29 (9.52)

<0.0001

70.34 (9.60)

73.84 (9.87)

<0.0001

Cholesterol

175.20 (32.50)

186.50 (34.55)

<0.0001

164.53 (33.53)

182.90 (37.08)

<0.0001

HDL-c

60.04 (8.63)

58.94 (8.55)

<0.0001

54.34 (6.79)

53.58 (7.73)

0.221

LDL-c

100.35 (31.89)

111.76 (33.92)

<0.0001

93.36 (33.22)

109.72 (35.54)

<0.0001

Triglycerides

74.07 (29.71)

79.13 (35.95)

<0.0001

85.01 (53.82)

99.10 (64.51)

<0.0001

Glycaemia

83.56 (10.96)

85.29 (12.22)

<0.0001

86.77 (19.19)

89.07 (17.49)

<0.0001

Percentage

Percentage

p-value

Percentage

Percentage

p-value

18–29 years

42.30

24.50

<0.0001

55.43

28.55

<0.0001

30–39 years

32.68

32.38

23.37

31.02

40–49 years

18.15

27.94

12.34

25.17

50–70 years

6.87

15.18

8.86

15.26

Social class I

8.08

8.46

1.51

5.17

Social class II

24.20

26.81

5.92

14.70

Social class III

67.72

64.73

92.57

80.13

Nonsmoker

64.60

66.90

64.95

65.78

Smoker

35.40

33.10

35.05

34.22

<0.0001

<0.0001

DBO: diastolic blood pressure; HDL-c: high density lipoproteins – cholesterol;
systolic blood pressure.

<0.0001

0.202

LDL-c: low density lipoproteins – cholesterol; SBP:

Table 2. Mean values of cardiovascular risk scales in underweight and normal weight by sex.
Underweight

Normal weight

Underweight

Normal weight

Men

Men

Women

Women

n

Mean (SD)

n

Mean (SD)

p-value n

ALLY vascular
age SCORE

518

6.08 (6.78)

37571 6.13 (6.48)

0.876

SCORE scale

518

1.34 (1.79)

37571 1.36 (1.95)

0.913

ALLY vascular
1091 0.46 (8.23)
age Framingham

66565 2.79 (8.66)

REGICOR scale

759

2.47 (1.76)

ERICE scale

1091 2.91 (3.29)

Mean (SD)

n

Mean (SD)

p-value

1436 2.54 (4.51)

39277

3.41 (4.94)

0.078

1436 0.23 (0.81)

39277

0.33 (0.81)

0.887

<0.0001 3325 –4.73 (7.62)

68914

–2.41 (9.68)

0.031

52194 2.75 (1.84)

0.124

2246 1.46 (1.21)

54453

1.84 (1.59)

0.221

66558 3.39 (3.99)

0.223

3325 1.73 (2.29)

68899

2.22 (2.76)

0.287
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Table 3. Prevalence of alterated values of cardiovascular risk scales in underweight and normal weight by sex.

n

Underweight

Normal weight

Underweight

Normal weight

Women
n = 5768

Women
n = 91,309

Men
n = 2448

Men
n = 93,186

Percentage

n

Percentage

p-value n

Percentage

n

Percentage

p-value

Hypertension

5768 3.48

91309 7.34

<0.0001 2448 8.21

93186 15.85

<0.0001

Cholesterol
≥200 mg/dL

5768 20.11

91309 32.05

<0.0001 2448 14.3

93186 30.17

<0.0001

LDL-c ≥130
mg/dL

5768 16.33

91309 27.03

<0.0001 2448 13.6

93186 27.15

<0.0001

Triglycerides
≥150 mg/dL

5768 2.46

91309 3.97

<0.0001 2448 6.62

93186 12.03

<0.0001

Glycaemia
5768 4.16
100–125 mg/dL

91309 6.16

0.310

2448 9.03

93186 12.24

0.112

Glycaemia >125
5768 0.29
mg/dL

91309 0.50

2448 1.92

93186 1.56

SCORE
moderate

1436 1.88

39277 2.52

518

12.36

37571 12.35

SCORE high

1436 0.28

39277 0.82

518

8.69

37571 7.64

REGICOR
moderate

2246 3.12

54453 6.23

759

9.99

52194 12.63

REGICOR
2246 0.09
high-very high

54453 0.41

759

0.92

52194 0.91

ERICE
moderate

3325 0.84

68899 1.58

1091 5.13

66558 5.87

ERICE highvery high

3325 0.12

68899 0.07

1091 0.27

66558 1.13

variables that most influence the appearance of high CVR
values. Social class and, to a lesser extent, weight gain also
seem to have an influence. That is why healthy lifestyle
changes are important to prevent future cardiometabolic
alterations that cause an increase in BMI and therefore
a worsening of the parameters that affect CVR, such
as increased blood pressure, fat mass percentage, the
increased abdominal and waist circumference, as well as
a worsening of laboratory parameters that refer to blood
glucose and lipid profile [22,23].
Unfortunately, we have not found articles similar to
ours that assess the level of CVR in this specific group, so
we cannot directly compare our results with those obtained
previously by other authors since most of the studies that
appear in the literature compare the changes in different
CVRF between a population with normal weight and with
obesity or overweight, but not between normal weight and

930

0.479

0.098

0.084

0.775

0.117

0.339

underweight population. This fact will allow our work to
be considered as a reference in this population and may
serve as a starting point for future research.
The study carried out by McEniery et al. [24], carried
out in 2511 persons aged between 18 and 40 years, free
of CVD and medication, in which the factors underlying
hypertension were assessed in normal weight versus obese
individuals showed that there were different mechanisms
involved in hypertension in both groups, so the individuals
with normal weight also had altered blood pressure levels,
something that has also been objectified in our study. In
the obese patients, the main mechanism was the increase
in cardiac output due to their larger body size. On the other
side, in normal weight individuals, the most important
mechanism was the increase in peripheral vascular
resistance, and it was also observed that BMI values were
higher in hypertensive individuals. Similarly, in our study,
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Table 4. Binary logistic regression.

≥ 50 years

Normal
weight

Men

Social
class III

OR
(95% CI)

p-value

OR
(95% CI)

p-value

OR
(95% CI)

Hypertension

4.33
(4.19–4.47)

<0.0001

2.45
(2.37–2.53)

<0.0001

1.89
1.22
<0.0001
<0.0001
(1.70–2.09)
(1.14–1.32)

ns

Cholesterol
≥200 mg/dL

4.01
(3.91–4.12)

<0.0001

0.92
(0.90–0.94)

<0.0001

1.84
1.15
<0.0001
<0.0001
(1.74–1.95)
(1.10–1.20)

ns

LDL-c
≥130 mg/dL

4.08
(3.98–4.19)

<0.0001

ns

1.82
1.14
<0.0001
<0.0001
(1.71–1.93)
(1.09–1.20)

ns

Triglycerides ≥150 2.05
mg/dL
(1.97–2.13)

<0.0001

3.23
(3.11–3.36)

<0.0001

1.71
1.28
0.95
<0.0001
<0.0001
(1.52–1.92)
(1.17–1.40)
(0.92–0.99)

0.009

Glycaemia
>125 mg/dL

4.79
(4.38–5.24)

<0.0001

3.05
(2.74–3.39)

<0.0001

SCORE
moderate-high

100.56
14.57
1.28
<0.0001
<0.0001
0.035
(90.30–111.98)
(13.53–15.70)
(1.02–1.61)

REGICOR
moderate-highvery high

22.50
2.47
<0.0001
(21.31–23.77)
(2.36–2.59)

<0.0001

1.76
1.49
3.48
<0.0001
<0.0001
<0.0001
(1.46–2.11)
(1.40–1.59)
(3.32–3.64)

ERICE moderatehigh-very high

61.32
5.62
<0.0001
(48.27–74.68)
(5.24–6.03)

<0.0001

1.27
0.042
(1.01–1.62)

it was demonstrated in a statistically significant way that
individuals with normal weight had altered values in
most of the parameters related to CVR, so that even if the
population are within the normal weight range, those with
a higher BMI will present worse results in the different
parameters analyzed as can be seen in the results of our
study.
The DORICA study, carried out by Millán et al. [25],
analyzed the prevalence of the different risk factors and
established that the most appropriate cut-off points to
establish a high CVR were BMI of 27 kg/m2 in women
and 30 kg/m2 in men. According to the World Health
Organization, they would be within the range of overweight
and obesity, so this study concludes that the higher the
BMI, the greater the risk of presenting and adverse event.
Therefore, referring to our study, those participants with a
higher BMI, despite being within the normal weight range,
also had a high CVR compared to underweight patients,
where their BMI was lower.
Other studies, such as the one carried out by Berg et
al. [11] or the study by Correa-Rodriguez et al. [22], or
the one by Elagizi et al. [26], evaluated the alterations
and CVR in people with normal weight, but who were

p-value

ns

OR
(95% CI)

Smokers

p-value

OR
(95% CI)

p-value

1.91
<0.0001
(1.68–2.18)

ns

1.28
7.81
<0.0001
(1.18–1.39)
(7.31–8.35)

<0.0001

1.26
2.62
<0.0001
(1.16–1.38)
(2.45–2.78)

<0.0001

considered obese since they had an excess of body fat [26].
This group, despite having a normal weight BMI, the CVR
was higher in those with a higher percentage of body fat
[22]. They also observed that when comparing the level of
CVR between people of normal weight (with and without
excess body fat), it was observed that those with excess fat
had higher triglyceride and LDL levels and lower HDL
levels, as well as higher blood pressure values [11].
To conclude, although most of the studies found in the
literature indicate that obese or overweight individuals
have a greater risk of developing adverse events due to
the increased CVR. The data provided in our study show
that populations with normal weight may also have altered
different parameters that influence CVR and therefore
have it increased, having a normal BMI, which indicates
that being in normal weight is not synonymous with the
absence of risk. That is why it is important to maintain a
healthy lifestyle, with adequate nutrition, daily physical
activity and avoid sedentary lifestyle in order to reduce
CVRFs.
The strengths of the study include the very large sample
size, almost 200,000 persons, the large number of CVRS
analyzed (REGICOR, CVR SCORE, ERICE, Framingham
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vascular age and SCORE vascular age) and the fact that it
is one of the few studies to have assessed CVR in persons
with low weight or normal weight without obesity. Most
of the articles found in the literature study CVR in normal
weight obese or in obese or overweight individuals.

Its limitations are that it was carried out in a specific
geographical area and in a working population, which
might limit the generalizability of our results to other areas
and to the general population.
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